KRW 193100.0
(-3.06%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 3041.45 Billion KRW | 393.46% |
2022 | 616.35 Billion KRW | 6.62% |
2021 | 578.05 Billion KRW | 50.41% |
2020 | 384.32 Billion KRW | 25.31% |
2019 | 306.7 Billion KRW | 88.26% |
2018 | 162.91 Billion KRW | -18.33% |
2017 | 199.48 Billion KRW | 7.97% |
2016 | 184.75 Billion KRW | -20.96% |
2015 | 233.76 Billion KRW | 4.54% |
2014 | 223.61 Billion KRW | 63.41% |
2013 | 136.84 Billion KRW | 75.42% |
2012 | 78 Billion KRW | 92.14% |
2011 | 40.59 Billion KRW | 86.67% |
2010 | 21.74 Billion KRW | 25.27% |
2009 | 17.36 Billion KRW | -30.09% |
2008 | 24.83 Billion KRW | 572.14% |
2007 | 3.69 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 2987.83 Billion KRW | -1.76% |
2024 Q2 | 2927.55 Billion KRW | -2.02% |
2023 Q2 | 505.27 Billion KRW | -2.76% |
2023 Q3 | 525.02 Billion KRW | 3.91% |
2023 Q1 | 519.64 Billion KRW | -15.69% |
2023 Q4 | 3041.45 Billion KRW | 479.29% |
2023 FY | 3041.45 Billion KRW | 393.46% |
2022 Q3 | 639.82 Billion KRW | -13.28% |
2022 Q4 | 616.35 Billion KRW | -3.67% |
2022 Q2 | 737.84 Billion KRW | 1.83% |
2022 FY | 616.35 Billion KRW | 6.62% |
2022 Q1 | 724.55 Billion KRW | 25.34% |
2021 Q3 | 545.92 Billion KRW | 23.6% |
2021 Q4 | 578.05 Billion KRW | 5.89% |
2021 Q1 | 438.81 Billion KRW | 14.18% |
2021 Q2 | 441.68 Billion KRW | 0.65% |
2021 FY | 578.05 Billion KRW | 50.41% |
2020 FY | 384.32 Billion KRW | 25.31% |
2020 Q2 | 357.08 Billion KRW | 15.6% |
2020 Q1 | 308.9 Billion KRW | 0.72% |
2020 Q4 | 384.32 Billion KRW | -3.06% |
2020 Q3 | 396.44 Billion KRW | 11.02% |
2019 Q3 | 266.72 Billion KRW | 4.37% |
2019 Q2 | 255.55 Billion KRW | 34.49% |
2019 FY | 306.7 Billion KRW | 88.26% |
2019 Q1 | 190.01 Billion KRW | 16.63% |
2019 Q4 | 306.7 Billion KRW | 14.99% |
2018 Q1 | 184.28 Billion KRW | -7.62% |
2018 Q4 | 162.91 Billion KRW | -12.26% |
2018 Q3 | 185.68 Billion KRW | -1.75% |
2018 FY | 162.91 Billion KRW | -18.33% |
2018 Q2 | 189 Billion KRW | 2.56% |
2017 FY | 199.48 Billion KRW | 7.97% |
2017 Q2 | 170.62 Billion KRW | -2.24% |
2017 Q3 | 197 Billion KRW | 15.46% |
2017 Q4 | 199.48 Billion KRW | 1.26% |
2017 Q1 | 174.53 Billion KRW | -5.53% |
2016 Q3 | 216.3 Billion KRW | -0.26% |
2016 Q4 | 184.75 Billion KRW | -14.58% |
2016 Q1 | 229.92 Billion KRW | -1.64% |
2016 FY | 184.75 Billion KRW | -20.96% |
2016 Q2 | 216.86 Billion KRW | -5.68% |
2015 Q4 | 233.76 Billion KRW | -4.08% |
2015 Q3 | 243.7 Billion KRW | -2.71% |
2015 FY | 233.76 Billion KRW | 4.54% |
2015 Q2 | 250.49 Billion KRW | 3.63% |
2015 Q1 | 241.72 Billion KRW | 8.1% |
2014 Q3 | 244 Billion KRW | 0.54% |
2014 Q2 | 242.7 Billion KRW | 5.46% |
2014 FY | 223.61 Billion KRW | 63.41% |
2014 Q4 | 223.61 Billion KRW | -8.36% |
2014 Q1 | 230.14 Billion KRW | 68.19% |
2013 FY | 136.84 Billion KRW | 75.42% |
2013 Q4 | 136.84 Billion KRW | 16.14% |
2013 Q3 | 117.82 Billion KRW | 14.81% |
2013 Q2 | 102.62 Billion KRW | 17.55% |
2013 Q1 | 87.29 Billion KRW | 11.91% |
2012 Q4 | 78 Billion KRW | 0.0% |
2012 Q1 | 49.57 Billion KRW | 0.0% |
2012 FY | 78 Billion KRW | 92.14% |
2011 Q1 | 26.27 Billion KRW | 20.83% |
2011 FY | 40.59 Billion KRW | 86.67% |
2011 Q3 | 36.99 Billion KRW | 36.33% |
2011 Q2 | 27.13 Billion KRW | 3.26% |
2010 Q1 | 19.36 Billion KRW | 11.54% |
2010 Q4 | 21.74 Billion KRW | 2.63% |
2010 FY | 21.74 Billion KRW | 25.27% |
2010 Q3 | 21.19 Billion KRW | -15.94% |
2010 Q2 | 25.21 Billion KRW | 30.18% |
2009 Q3 | 12.32 Billion KRW | -34.58% |
2009 Q2 | 18.83 Billion KRW | -3.02% |
2009 Q1 | 19.42 Billion KRW | -21.79% |
2009 FY | 17.36 Billion KRW | -30.09% |
2009 Q4 | 17.36 Billion KRW | 40.89% |
2008 Q3 | 26.27 Billion KRW | 766.85% |
2008 Q1 | 3.66 Billion KRW | 0.0% |
2008 FY | 24.83 Billion KRW | 572.14% |
2008 Q2 | 3.03 Billion KRW | -17.33% |
2008 Q4 | 24.83 Billion KRW | -5.49% |
2007 Q3 | 2.6 Billion KRW | 10.22% |
2007 Q1 | 2.05 Billion KRW | 0.0% |
2007 Q2 | 2.36 Billion KRW | 15.21% |
2007 FY | 3.69 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ORIENT BIO Inc. | 3.65 Billion KRW | -83126.924% |
Green Cross Holdings Corporation | 579.72 Billion KRW | -424.634% |
Green Cross Holdings Corporation | 516.24 Billion KRW | -489.149% |
Pharmicell Co., Ltd. | 20.87 Billion KRW | -14471.663% |
Green Cross Corporation | 516.24 Billion KRW | -489.149% |
GeneOne Life Science, Inc. | 14.89 Billion KRW | -20316.621% |
Samsung Biologics Co.,Ltd. | 2641.36 Billion KRW | -15.147% |
SK bioscience Co.,Ltd. | 80.64 Billion KRW | -3671.205% |
SK Biopharmaceuticals Co., Ltd. | 102.52 Billion KRW | -2866.533% |
Prestige BioPharma Limited | 18.1 Billion KRW | -16700.824% |